Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/14/16 → 10/14/22 |
Funding
- Merck Sharp & Dohme Corporation (Prot #NU 15U06)
Prot #NU 15U06: A Phase 1 Dose-Escalation Study of Intravesical MK-3475 and Bacillus Calmette-Guerin (BCG) in Subjects with High Risk and BCG-Refractory Non-Muscle-Invasive Bladder Cancer
- Meeks, Joshua J (PD/PI)
Project: Research project